We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Stanbio Expands International Distribution

By Labmedica staff writers
Posted on 14 Mar 2002
In a move to expand the distribution of its products, Stanbio Laboratory (Boerne, TX, USA) has agreed for BDS International Diagnostics Gmbh (Schwetzingen, Germany) to serve as the export sales office of Stanbio in Eastern and Western Europe, the Middle East, and the Indian subcontinent. BDS' services will include supporting and managing existing distributors and selecting and training additional distributors.

Stanbio has been producing and marketing clinical diagnostic reagents and test kits since 1960. The company's in vitro diagnostic products include clinical chemistry, serology, pregnancy, urinalysis, occult blood, microbiology, hematology, blood-grouping products, and clinical instruments. Stanbio now supplies liquid-stable and dry-powder clinical reagents as well as innovative dry-chemistry systems.

"Our product offerings will be highly attractive to the European markets, and in BDS we have a partner who shares our philosophy of quality and service,” said William R. Pippin, president of Stanbio.




Related Links:
Stanbio
BDS

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Prefilled Tubes
Prefilled 5.0ml Tubes

Latest Industry News

Integrated DNA Technologies Expands into Clinical Diagnostics
14 Mar 2002  |   Industry

Co-Diagnostics Agreement Expands Commercial and Distribution Reach in South Asia
14 Mar 2002  |   Industry

Automated MSI Test Gains IVDR Certification to Guide CRC Therapy
14 Mar 2002  |   Industry



INTEGRA BIOSCIENCES AG